| Outer membrane protein A of bovine and ovine isolates of Mannheimia haemolytica is surface exposed and contains host species-specific epitopes JDA Hounsome, S Baillie, M Noofeli, A Riboldi-Tunnicliffe, ... Infection and immunity 79 (11), 4332-4341, 2011 | 33 | 2011 |
| Safety and efficacy of combined intramuscular/intranasal RAZI-COV PARS vaccine candidate against SARS-CoV-2: a preclinical study in several animal models SR Banihashemi, A Es-Haghi, MH Fallah Mehrabadi, M Nofeli, ... Frontiers in Immunology 13, 836745, 2022 | 31 | 2022 |
| BapC autotransporter protein is a virulence determinant of Bordetella pertussis M Noofeli, H Bokhari, P Blackburn, M Roberts, JG Coote, R Parton Microbial pathogenesis 51 (3), 169-177, 2011 | 28 | 2011 |
| A new vaccine delivery vehicle and adjuvant candidate: Bordetella pertussis inactivated whole cells entrapped in alginate microspheres N Dounighi, F Shahcheraghi, M Razzaghi-Abyaneh, M Nofeli, ... Current Pharmaceutical Design 23 (18), 2665-2672, 2017 | 7 | 2017 |
| Preparation and evaluation of alginate nanoparticles containing pertussis toxin as a particulate delivery system HR Goudarzi, AR Mokarram, M Noofeli, AN Shirvan, M Saadati Int. J. Adv. Biotechnol. Res 7 (2), 558-564, 2016 | 7 | 2016 |
| Molecular detection of pathogenic leptospiral serovars by PCR, based on lipL21 gene R Hoseinpur, P Khaki, M Noofeli, S Moradi Bidhendi Archives of Razi Institute 70 (4), 223-227, 2015 | 7 | 2015 |
| Immunogenicity and safety of a combined intramuscular/intranasal recombinant spike protein COVID-19 vaccine (RCP) in healthy adults aged 18 to 55 years old: a randomized … MS Dodaran, SR Banihashemi, A Es-Haghi, MHF Mehrabadi, M Nofeli, ... Vaccines 11 (2), 455, 2023 | 6 | 2023 |
| Outer membrane vesicles of bordetella pertussis encapsulated into sodium alginate nanoparticles as novel vaccine delivery system A Rami, F Kazemi-Lomedasht, A Mirjalili, M Noofeli, F Shahcheraghi, ... Current Pharmaceutical Design 27 (42), 4341-4354, 2021 | 6 | 2021 |
| Genome diversity and evolutionary characteristics of clinical isolates of Bordetella pertussis circulating in Iran S Saedi, A Safarchi, M Noofeli, K Tadayon, ACY Tay, B Lamichhane, ... Iranian Journal of Microbiology 12 (1), 1, 2020 | 6 | 2020 |
| Genetic analysis of clinical and vaccine strains of Bordetella pertussis by pulsed-field gel electrophoresis (PFGE), multi locus sequence typing (MLST) and serotyping A Bahmanjeh, M Noofeli, P Khaki, SM Hassanzadeh Comparative immunology, microbiology and infectious diseases 64, 168-175, 2019 | 6 | 2019 |
| Bradykinin-potentiating factors of venom from iranian medically important scorpions HR Goudarzi, Z Salehi Najafabadi, A Movahedi, M Noofeli Archives of Razi Institute 74 (4), 385-394, 2019 | 5 | 2019 |
| Study on toxicity reduction and potency induction in whole-cell pertussis vaccine by developing a new optimal inactivation condition processed on Bordetella pertussis NM Dounighi, M Razzaghi-Abyane, M Nofeli, H Zolfagharian, ... Jundishapur Journal of Microbiology 9 (7), 2016 | 5 | 2016 |
| Comparison of two different methods for the extraction of outer membrane vesicles from the Bordetella pertussis as a vaccine candidate F Eftekhar, M Noofeli, F Shahcheraghi Archives of Razi Institute 76 (3), 411, 2021 | 4 | 2021 |
| Bioassay of derived components from venom of Iranian medically important scorpions to identify the bradykinin potentiating factors HR Goudarzi, A Nazari, M Noofeli, M Samiani bioRxiv, 210856, 2017 | 4 | 2017 |
| A novel method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis Tohama strain M Sekhavati, AM Mobarez, SD Siadat, M Noofeli Iranian Journal of Microbiology 12 (1), 37, 2020 | 3 | 2020 |
| Engineering of an Iranian Bordetella pertussis strain producing inactive pertussis toxin VS Nikbin, M Keramati, M Noofeli, F Tayebzadeh, B Kahali, ... Journal of Medical Microbiology 69 (1), 111-119, 2020 | 3 | 2020 |
| Genetic analysis and characterisation of the BapC autotransporter of bordetella pertussis M Noofeli University of Glasgow, 2008 | 3 | 2008 |
| Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial S Erfanpoor, SR Banihashemi, L Mokhbaeralsafa, S Kalantari, ... BMC medicine 22 (1), 78, 2024 | 2 | 2024 |
| Investigating preparation and characterisation of diphtheria toxoid‐loaded on sodium alginate nanoparticles S Aghamiri, M Noofeli, P Saffarian, Z Salehi Najafabadi, HR Goudarzi IET nanobiotechnology 16 (5), 199-209, 2022 | 2 | 2022 |
| Comparative assessment of the whole-cell pertussis vaccine potency using serological and intracerebral mouse protection methods D Mohammadbagher, M Noofeli, G Karimi Archives of Razi Institute 74 (2), 103-109, 2019 | 2 | 2019 |
